<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01273987</url>
  </required_header>
  <id_info>
    <org_study_id>Neobladder-01</org_study_id>
    <nct_id>NCT01273987</nct_id>
  </id_info>
  <brief_title>Neobladder Posterior Wall Suspended With Round Ligament of Uterus</brief_title>
  <official_title>Neobladder Posterior Wall Suspended With Round Ligament of Uterus After Radical Cystectomy in Female With Bladder Cancer â€”a Prospective Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhiwen Chen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: to evaluate if the Neobladder posterior wall suspended with round ligament of
      uterus could improve neobladder empty after radical cystectomy in female patients with
      bladder cancer compared to present standard neobladder
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators developed a technical modification which to aim to provide an posterior
      support to the ideal neobladder and obtain the anatomy recovered neobladder by posterior wall
      of neobladder suspended with round ligament. In this study the investigators designed the
      prospective random trial to evaluate whether this technique improves the neobladder empty
      compared to a current standard neobladder reconstruction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2011</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">November 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postvoiding residual urine (PVP)</measure>
    <time_frame>2 years after operation</time_frame>
    <description>number of patients with postvoiding residual urine (PVP) more than 100ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clean intermittent catheterization(CIC)</measure>
    <time_frame>2 years after operation</time_frame>
    <description>number of patients required clean intermittent catheterization(CIC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of complication</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>number of patients with any complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urodynamic profile</measure>
    <time_frame>12 months afer operation</time_frame>
    <description>urodynamic parameter including peak flow rate, functional urethral length ...etc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of continence of neobladder</measure>
    <time_frame>12 months after operation</time_frame>
    <description>number of patients with continence at daytime and nighttime</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Female</condition>
  <condition>Bladder Cancer</condition>
  <condition>Radical Cystectomy</condition>
  <condition>Neobladder</condition>
  <condition>Posterior Wall Suspended With Round Ligament of Uterus</condition>
  <arm_group>
    <arm_group_label>neobladder with round lig</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ileal neobladder suspened with round ligament</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard neobladder</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional standard neobladder</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>rONB</intervention_name>
    <description>Neobladder posterior wall suspended with round ligament of uterus after radical cystectomy in female with bladder cancer</description>
    <arm_group_label>neobladder with round lig</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The inclusion criteria for the study were bladder cancer (Stage T1G3, T2-3N0-NxM0),
             female (age between 40 and 70 years old), no history of urethral trauma or urethral
             stricture; and a desire to obtain an orthotopic neobladder

        Exclusion Criteria:

          -  The exclusion criteria were male sex, posterior urethral margin confirmed as cancer
             invasive by pathology; and enteritis. The indications and contraindications for
             orthotopic reconstruction in this study conformed to the criteria set by the
             guidelines of the European Association of Urology on bladder cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZhiWen Chen, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Urology Institute of PLA, Southwest Hospital, Chongqin, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HuiXiang Ji, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology Institute of PLA, Southwest Hospital, Chongqin, China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology Institute of PLA, Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 7, 2011</study_first_submitted>
  <study_first_submitted_qc>January 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2011</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Zhiwen Chen</investigator_full_name>
    <investigator_title>Vice director of urological institiute of PLA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

